Three buildings rented by pharmacy chain MediCare have gone on the market, Business Telegraph can reveal.
The sites in Dundonald, Glengormley and Broughshane have been put up for sale, with the pharmacy businesses still in rental contracts until at least 2025.
Out of 52 MediCare shops here, 34 are now involved in the rollout of the Covid-19 vaccine.
Medicare operations director Aidan McKegney said the process did not mean closure of the stores.
"There are no MediCare outlets for sale. There are some properties which have been put on the market by the landlord, but this does not include any MediCare business."
Brian Kidd from selling agents Frazer Kidd added: "The buildings are being sold as income producing property investments. The properties are therefore being offered for sale with the benefit of the existing leases. As such the trading businesses are not affected and are not part of the proposed sales."
A two-storey building on Comber Road in Dundonald is for sale from £380,000. It features a MediCare unit on the ground floor and a two-bed apartment on the first floor. Another site on Ballyclare Road in Glengormley is seeking offers from £385,000, while on Main Street, Broughshane, a two-storey property is selling for £405,000.
Medicare is among almost 350 community pharmacies taking part in the local Covid vaccination campaign. The Department of Health will pay pharmacies who participate £12.58 per vaccination, or £25.16 per completed course of two doses.
On its most recent financial report, for the year ending August 31, 2019, Magir Ltd - the company name for MediCare - published a rise in turnover of £1.2m to £77.5m.
Along with Gordons Chemists, MediCare is one of two large local groups of high street pharmacies. It was set up by director Michael Guerin, who registered as a pharmacist in 1987 and acquired his first pharmacy in 1988. Today it employs around 509 staff.
Health Minister Robin Swann said using community pharmacies for vaccinations "will help speed up the rollout of the existing programme by increasing capacity and local accessibility to vaccines for the general population, particularly for those who may find it more difficult to travel to one of the mass vaccinations centres".